PDS Biotechnology Corp (PDSB)
↓ Download CSVKey ratios (FY2025)
-372.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$31.54M | -$36.32M | -$43.05M | -$41.67M | -$21.44M | -$14.90M | -$21.03M | -$3.65M | -$51.97M | -$39.51M |
| Net Income | -$34.50M | -$37.61M | -$42.94M | -$40.85M | -$16.92M | -$14.85M | -$7.00M | -$3.84M | -$50.86M | -$38.82M |
| EPS (Diluted) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 | $-0.89 | — | — | — | — |
| Total Assets | $30.49M | $45.36M | $59.39M | $77.01M | $67.20M | $30.89M | $14.49M | $164.4K | $92.62M | $110.91M |
| Total Liabilities | $21.24M | $26.35M | $33.26M | $33.01M | $3.99M | $3.76M | $2.79M | $2.23M | — | — |
| Shareholders' Equity | $9.25M | $19.00M | $26.13M | $44.00M | $63.21M | $27.13M | $11.70M | -$2.07M | -$609.5K | $89.28M |
| Cash & Equivalents | $26.71M | $41.69M | $56.56M | $73.82M | $65.24M | $28.84M | $12.16M | $103.7K | $88.07M | $106.40M |
| Operating Cash Flow | -$27.75M | -$35.03M | -$33.64M | -$25.71M | -$12.49M | -$13.15M | -$18.07M | -$1.57M | -$40.70M | -$32.19M |
| Capital Expenditures | $0 | $29.0K | $0 | — | — | — | — | $0 | $188.7K | $686.7K |
| Shares Outstanding | 54.88M | 37.99M | 33.09M | 30.17M | 28.45M | 22.26M | 5.28M | 3.42M | 30.87M | 28.92M |